|
TPD52 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
5.55111512312578E-16 |
| Normal-vs-Stage3 |
2.71729999612447E-08 |
| Normal-vs-Stage4 |
2.288000E-02 |
| Stage1-vs-Stage2 |
8.986800E-01 |
| Stage1-vs-Stage3 |
1.338200E-02 |
| Stage1-vs-Stage4 |
6.720200E-03 |
| Stage2-vs-Stage3 |
1.357610E-02 |
| Stage2-vs-Stage4 |
2.966300E-02 |
| Stage3-vs-Stage4 |
2.993000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.23621121619999E-12 |
| Normal-vs-Asian |
1.018980E-01 |
| Caucasian-vs-AfricanAmerican |
2.767800E-01 |
| Caucasian-vs-Asian |
3.621500E-02 |
| AfricanAmerican-vs-Asian |
3.185600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.44249065417534E-15 |
| Male-vs-Female |
8.636000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.37799804689598E-11 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
9.507800E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.978200E-02 |
| Normal_Weight-vs-Obese |
5.633200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.866200E-01 |
| Extreme_Weight-vs-Obese |
9.764700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.084800E-01 |
| Obese-vs-Extreme_Obese |
7.732000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.823700E-04 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
9.54791801177635E-15 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.497400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.302200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.202800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.097000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.019880E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.944200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.62458935193399E-12 |
| Normal-VS-KIRP CIMP |
3.497500E-02 |
| Normal-VS-Unclassified PRCC |
1.62458935193399E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.620090E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.6610046671417E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
2.941500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
8.805800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.723800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.90860000004456E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
6.152200E-04 |
| Normal-vs-N2 |
1.277850E-02 |
| N0-vs-N1 |
4.026700E-04 |
| N0-vs-N2 |
1.543820E-02 |
| N1-vs-N2 |
9.583200E-01 |
|
|
